Anticorps Recombinant de lapin anti-Phospho-AKT (Thr308)

Phospho-AKT (Thr308) Recombinant Antibody for WB, FC (Intra), Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, FC (Intra), Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

241845F1

N° de cat : 81232-8-PBS

Synonymes

AKT pan, AKT 1, AKT (pan), AKT, AKT1



Informations sur le produit

81232-8-PBS cible Phospho-AKT (Thr308) dans les applications de WB, FC (Intra), Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène Peptide
Nom complet v-akt murine thymoma viral oncogene homolog 1
Masse moléculaire calculée 56 kDa
Poids moléculaire observé60 kDa
Numéro d’acquisition GenBankBC000479
Symbole du gène AKT1
Identification du gène (NCBI) 207
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Protein A purfication
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

The serine-threonine kinase Akt, also known as protein kinase B (PKB), contributes to a broad range of cellular functions including cell survival, proliferation, gene expression and migration of cells of most lineages. AKT has a wide range of cellular substrates, and the oncogenicity of AKT arises from activation of both proliferative and anti-apoptotic signaling, thus making this kinase an attractive target for cancer therapy. Activation of mammalian AKT depends on its recruitment to the membrane through binding of phosphatidylinositol-3,4,5-trisphosphate (PIP3) to the PH domain of AKT, and subsequent phosphorylation at two key residues, Thr308 and Ser473, located at the catalytic domain and C-terminal regulatory domain, respectively. (PMID: 34740102, PMID: 29017516)

{{ptg:RelatedPrimaryAntibodies}}